A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cukurova University
• Treatments: Dexmedetomidine; Morphine

Criteria

Inclusion Criteria:

• patients with chronic cancer pain

• between 20-80 years old age

Exclusion Criteria:

• the presence of severe systemic disease(cardiac, pulmonary, hepatic or renal)

• psychiatric or neurologic disease

• unable to communicate verbally

• nausea and vomiting

• patient's refusal